Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Priothera SAS

Clinicaltrial registered13 Nov 2026

Priothera SAS

13 Nov 2026: Trial registered · Single and Multiple Ascending Dose Study of KRP-203 in Healthy Japanese Adults. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
13 Nov 2026
Title
Single and Multiple Ascending Dose Study of KRP-203 in Healthy Japanese Adults
Conditions
Healthy Vollunteer
Phase
Phase 1
Study Type
Interventional
Status
Completed
Reference
NCT07937046
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Priothera SAS

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.